Helixor A enhances natural killer cell activity by induction of PAI-1 expression through the p38/MAPK signaling pathway.
Helixor A, an anticancer drug, has an immunostimulatory effect that increases T and natural killer (NK) cell activity in patients with cancer and endometriosis. However, the molecular mechanisms underlying its …
Understanding Endometriosis: A Broad Review of Its Causes, Management, and Impact.
Endometriosis is a complex gynecological condition affecting 10% of women globally, characterized by the growth of endometrial-like tissue outside the uterus, leading to chronic pelvic pain, infertility, reduced quality of …